BEMPEDOIC ACID / EZETIMIBE (Nustendi®)
Clinical Indication
Primary hypercholesterolaemia or mixed dyslipidaemia and secondary prevention in adults
Date of classification
September 2022
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.